Ahmed El Ray

Ahmed El Ray

Theodor Bilharz Research Institute - Cairo / Egypt
Medical and Health Sciences / Gastroenterology
AD Scientific Index ID: 4522557
-
person_outline Ahmed El Ray's MOST POPULAR ARTICLES
1-) Twelve weeks posttreatment follow‐up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon …M Martinot‐Peignoux, C Stern, S Maylin, MP Ripault, N Boyer, L Leclere, ...Hepatology 51 (4), 1122-1126, 20102372010
2-) IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis CT Asselah, S De Muynck, P Broët, J Masliah-Planchon, M Blanluet, ...Journal of hepatology 56 (3), 527-532, 20122022012
3-) High predictive value of early viral kinetics in retreatment with peginterferon and ribavirin of chronic hepatitis C patients non-responders to standard combination therapyR Moucari, MP Ripault, V Oulès, M Martinot-Peignoux, T Asselah, N Boyer, ...Journal of hepatology 46 (4), 596-604, 2007622007
4-) Urinary neutrophil gelatinase-associated lipocalin in cirrhotic patients with acute kidney injuryHS Hamdy, A El-Ray, M Salaheldin, M Lasheen, M Aboul-Ezz, ...Annals of hepatology 17 (4), 624-630, 2018392018
5-) Efficacy and safety of a novel pegylated interferon alpha-2a in Egyptian patients with genotype 4 chronic hepatitis CAA Taha, A El-Ray, M El-Ghannam, B MounirCanadian Journal of Gastroenterology 24 (10), 597, 2010312010